Cargando…
Extent of neck dissection for patients with clinical N1 oral cancer
BACKGROUND: No clear consensus has been reached on the indication of supraomohyoid neck dissection (SOHND) for clinically positive lymph-node metastasis. PATIENTS: Consecutive 100 patients with previously untreated oral cancer treated at Kobe University Hospital were included in this study. All pati...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261274/ https://www.ncbi.nlm.nih.gov/pubmed/32140953 http://dx.doi.org/10.1007/s10147-020-01635-8 |
_version_ | 1783540473838698496 |
---|---|
author | Kakei, Yasumasa Komatsu, Hirokazu Minamikawa, Tsutomu Hasegawa, Takumi Teshima, Masanori Shinomiya, Hirotaka Otsuki, Naoki Nibu, Ken-ichi Akashi, Masaya |
author_facet | Kakei, Yasumasa Komatsu, Hirokazu Minamikawa, Tsutomu Hasegawa, Takumi Teshima, Masanori Shinomiya, Hirotaka Otsuki, Naoki Nibu, Ken-ichi Akashi, Masaya |
author_sort | Kakei, Yasumasa |
collection | PubMed |
description | BACKGROUND: No clear consensus has been reached on the indication of supraomohyoid neck dissection (SOHND) for clinically positive lymph-node metastasis. PATIENTS: Consecutive 100 patients with previously untreated oral cancer treated at Kobe University Hospital were included in this study. All patients were clinically staged as anyTN1M0 and underwent radical dissection of the primary site and level I–V neck dissection as the initial treatment. RESULTS: None of the 100 patients had pathological lymph-node metastasis (pLN) to level V. pLN to level IV was observed in two patients with tongue cancer in whom clinical lymph-node metastasis was preoperatively observed at level II. CONCLUSIONS: Level V may be excluded in the neck dissection for patients with N1 oral cancers. Level IV dissection should be considered in the patient with tongue cancer and clinical lymph-node metastasis at level II. |
format | Online Article Text |
id | pubmed-7261274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-72612742020-06-10 Extent of neck dissection for patients with clinical N1 oral cancer Kakei, Yasumasa Komatsu, Hirokazu Minamikawa, Tsutomu Hasegawa, Takumi Teshima, Masanori Shinomiya, Hirotaka Otsuki, Naoki Nibu, Ken-ichi Akashi, Masaya Int J Clin Oncol Original Article BACKGROUND: No clear consensus has been reached on the indication of supraomohyoid neck dissection (SOHND) for clinically positive lymph-node metastasis. PATIENTS: Consecutive 100 patients with previously untreated oral cancer treated at Kobe University Hospital were included in this study. All patients were clinically staged as anyTN1M0 and underwent radical dissection of the primary site and level I–V neck dissection as the initial treatment. RESULTS: None of the 100 patients had pathological lymph-node metastasis (pLN) to level V. pLN to level IV was observed in two patients with tongue cancer in whom clinical lymph-node metastasis was preoperatively observed at level II. CONCLUSIONS: Level V may be excluded in the neck dissection for patients with N1 oral cancers. Level IV dissection should be considered in the patient with tongue cancer and clinical lymph-node metastasis at level II. Springer Singapore 2020-03-05 2020 /pmc/articles/PMC7261274/ /pubmed/32140953 http://dx.doi.org/10.1007/s10147-020-01635-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Original Article Kakei, Yasumasa Komatsu, Hirokazu Minamikawa, Tsutomu Hasegawa, Takumi Teshima, Masanori Shinomiya, Hirotaka Otsuki, Naoki Nibu, Ken-ichi Akashi, Masaya Extent of neck dissection for patients with clinical N1 oral cancer |
title | Extent of neck dissection for patients with clinical N1 oral cancer |
title_full | Extent of neck dissection for patients with clinical N1 oral cancer |
title_fullStr | Extent of neck dissection for patients with clinical N1 oral cancer |
title_full_unstemmed | Extent of neck dissection for patients with clinical N1 oral cancer |
title_short | Extent of neck dissection for patients with clinical N1 oral cancer |
title_sort | extent of neck dissection for patients with clinical n1 oral cancer |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261274/ https://www.ncbi.nlm.nih.gov/pubmed/32140953 http://dx.doi.org/10.1007/s10147-020-01635-8 |
work_keys_str_mv | AT kakeiyasumasa extentofneckdissectionforpatientswithclinicaln1oralcancer AT komatsuhirokazu extentofneckdissectionforpatientswithclinicaln1oralcancer AT minamikawatsutomu extentofneckdissectionforpatientswithclinicaln1oralcancer AT hasegawatakumi extentofneckdissectionforpatientswithclinicaln1oralcancer AT teshimamasanori extentofneckdissectionforpatientswithclinicaln1oralcancer AT shinomiyahirotaka extentofneckdissectionforpatientswithclinicaln1oralcancer AT otsukinaoki extentofneckdissectionforpatientswithclinicaln1oralcancer AT nibukenichi extentofneckdissectionforpatientswithclinicaln1oralcancer AT akashimasaya extentofneckdissectionforpatientswithclinicaln1oralcancer |